Executive search underway for permanent CFO
LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V., (NASDAQ:OFIX) today announced that it has
appointed David E. Ziegler as Interim Chief Financial Officer (CFO). Mr.
Ziegler succeeds Emily Buxton who has voluntarily resigned from the
Company. Orthofix and its Board of Directors are conducting an executive
search to identify a permanent CFO.
Mr. Ziegler has served as a full-time independent advisor to the Audit
Committee of the Board in connection with the independent review of
certain accounting matters. In that capacity, he assisted Orthofix and
its finance department in their preparation of the Company's recently
filed financial statement restatement, and subsequent reporting of 2013
financial results.
"Emily has been a dedicated and tireless team member for more than 11
years. I want to thank her for the hard work and contributions she has
made to the Company and we wish Emily success in her new endeavors,"
said President and Chief Executive Officer Brad Mason. "Additionally, I
am confident with David's strong financial and accounting background and
successful track record serving in several interim CFO positions, that
he will be an excellent contributor in this role."
David E. Ziegler
With more than 40 years' experience, Mr. Ziegler has held a wide range
of CFO and consulting roles including serving as interim Chief Financial
Officer of, and transition consultant to, Exopack Holding Corp., and a
financial consultant to PetroLogistics LLC, Critical Information
Network, LLC, and Lighting Science Group Corporation. He also served as
CFO and interim President of The UniMark Group, Inc. Mr. Ziegler spent
the first 20 years of his career as an auditor with Arthur Andersen, the
last eight as an audit partner in its Detroit and Dallas offices.
Mr. Ziegler received his Bachelor of Arts degree in Accounting and
Finance, along with a Minor in Economics, from Michigan State
University, and currently serves as a director of the Grant Halliburton
Foundation, a non-profit organization located in Dallas, Texas. Mr.
Ziegler has been a licensed certified public accountant in the State of
Texas since 1981.
About Orthofix
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville TX, the company has
four strategic business units that include BioStim, Biologics, Extremity
Fixation and Spine Fixation. Orthofix products are widely distributed
via the company's sales representatives, stocking distributors and
subsidiaries. In addition, Orthofix is collaborating on research and
development activities with leading clinical organizations such as the
Musculoskeletal Transplant Foundation, the Orthopedic Research and
Education Foundation and the Texas Scottish Rite Hospital for Children.
For more information, please visit www.orthofix.com.
Orthofix International N.V.
Mark Quick, 214-937-2924
Investor
Relations
markquick@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media